BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 31201834)

  • 1. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.
    Liu Y; Lu T; Zhang C; Xu J; Xue Z; Busuttil RW; Xu N; Xia Q; Kupiec-Weglinski JW; Ji H
    J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary Adenylate Cyclase-activating Polypeptides Prevent Hepatocyte Damage by Promoting Yes-associated Protein in Liver Ischemia-Reperfusion Injury.
    Liu Y; Lu T; Zhang C; Xue Z; Xu J; Busuttil RW; Xia Q; Xu N; Kupiec-Weglinski JW; Ji H
    Transplantation; 2019 Aug; 103(8):1639-1648. PubMed ID: 31348437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation of hepatic stellate cells, mediated by YAP and TAZ, contributes to liver repair and regeneration after liver ischemia-reperfusion injury.
    Konishi T; Schuster RM; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2018 Apr; 314(4):G471-G482. PubMed ID: 29351389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo-B is a key mediator of hepatic ischemia and reperfusion injury.
    Rao J; Cheng F; Zhou H; Yang W; Qiu J; Yang C; Ni X; Yang S; Xia Y; Pan X; Zhang F; Lu L; Wang X
    Redox Biol; 2020 Oct; 37():101745. PubMed ID: 33099216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants.
    Ke B; Shen XD; Zhang Y; Ji H; Gao F; Yue S; Kamo N; Zhai Y; Yamamoto M; Busuttil RW; Kupiec-Weglinski JW
    J Hepatol; 2013 Dec; 59(6):1200-7. PubMed ID: 23867319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation by the cAMP-PKA pathway.
    Ji H; Zhang Y; Shen XD; Gao F; Huang CY; Abad C; Busuttil RW; Waschek JA; Kupiec-Weglinski JW
    Hepatology; 2013 Mar; 57(3):1225-37. PubMed ID: 22532103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGR5 Attenuated Liver Ischemia-Reperfusion Injury by Activating the Keap1-Nrf2 Signaling Pathway in Mice.
    Zhuang L; Ding W; Zhang Q; Ding W; Xu X; Yu X; Xi D
    Inflammation; 2021 Jun; 44(3):859-872. PubMed ID: 33169298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFAIP3 Interacting Protein 3 Is an Activator of Hippo-YAP Signaling Protecting Against Hepatic Ischemia/Reperfusion Injury.
    Zhou J; Hu M; He M; Wang X; Sun D; Huang Y; Cheng X; Fu J; Cai J; Ma T; Tian S; Hu Y; Hu F; Liu D; He Y; Yan L; She ZG; Zhang XJ; Ji YX; Liu H; Li H; Yang H; Zhang P
    Hepatology; 2021 Oct; 74(4):2133-2153. PubMed ID: 34133792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4
    Kojima H; Kadono K; Hirao H; Dery KJ; Kupiec-Weglinski JW
    Antioxid Redox Signal; 2023 Mar; 38(7-9):670-683. PubMed ID: 36070449
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic fibroblast growth factor protects against liver ischemia-reperfusion injury via the Nrf2/Hippo signaling pathway.
    Chen X; Tong G; Chen S
    Tissue Cell; 2022 Dec; 79():101921. PubMed ID: 36150335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.
    Palumbo T; Nakamura K; Lassman C; Kidani Y; Bensinger SJ; Busuttil R; Kupiec-Weglinski J; Zarrinpar A
    Transplantation; 2017 Feb; 101(2):322-331. PubMed ID: 27820779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cyclic adenosine monophosphate-dependent protein kinase a signaling prevents liver ischemia/reperfusion injury in mice.
    Ji H; Shen XD; Zhang Y; Gao F; Huang CY; Chang WW; Lee C; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Liver Transpl; 2012 Jun; 18(6):659-70. PubMed ID: 22290937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Soluble Form of P Selectin Glycoprotein Ligand 1 Requires Signaling by Nuclear Factor Erythroid 2-Related Factor 2 to Protect Liver Transplant Endothelial Cells Against Ischemia-Reperfusion Injury.
    Zhang C; Zhang Y; Liu Y; Liu Y; Kageyama S; Shen XD; Gao F; Zheng S; Busuttil RW; Shaw GD; Ji H; Kupiec-Weglinski JW
    Am J Transplant; 2017 Jun; 17(6):1462-1475. PubMed ID: 27977895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Antigen R (HuR): A Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplant Injury.
    Dery KJ; Nakamura K; Kadono K; Hirao H; Kageyama S; Ito T; Kojima H; Kaldas FM; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2020 Sep; 72(3):1056-1072. PubMed ID: 31879990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate-protein kinase a pathway.
    Ji H; Zhang Y; Liu Y; Shen XD; Gao F; Nguyen TT; Busuttil RW; Waschek JA; Kupiec-Weglinski JW
    Liver Transpl; 2013 Sep; 19(9):945-56. PubMed ID: 23744729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant relaxin protects liver transplants from ischemia damage by hepatocyte glucocorticoid receptor: From bench-to-bedside.
    Kageyama S; Nakamura K; Fujii T; Ke B; Sosa RA; Reed EF; Datta N; Zarrinpar A; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2018 Jul; 68(1):258-273. PubMed ID: 29350771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage heme oxygenase-1-SIRT1-p53 axis regulates sterile inflammation in liver ischemia-reperfusion injury.
    Nakamura K; Zhang M; Kageyama S; Ke B; Fujii T; Sosa RA; Reed EF; Datta N; Zarrinpar A; Busuttil RW; Araujo JA; Kupiec-Weglinski JW
    J Hepatol; 2017 Dec; 67(6):1232-1242. PubMed ID: 28842295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor erythroid 2-related factor 2 regulates toll-like receptor 4 innate responses in mouse liver ischemia-reperfusion injury through Akt-forkhead box protein O1 signaling network.
    Huang J; Yue S; Ke B; Zhu J; Shen XD; Zhai Y; Yamamoto M; Busuttil RW; Kupiec-Weglinski JW
    Transplantation; 2014 Oct; 98(7):721-8. PubMed ID: 25171655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serelaxin induces Notch1 signaling and alleviates hepatocellular damage in orthotopic liver transplantation.
    Kageyama S; Nakamura K; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Am J Transplant; 2018 Jul; 18(7):1755-1763. PubMed ID: 29464890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin 1 attenuates inflammation and hepatocellular damage in liver transplant ischemia/Reperfusion: From mouse to human.
    Nakamura K; Kageyama S; Ke B; Fujii T; Sosa RA; Reed EF; Datta N; Zarrinpar A; Busuttil RW; Kupiec-Weglinski JW
    Liver Transpl; 2017 Oct; 23(10):1282-1293. PubMed ID: 28719070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.